Oracle Corp. filings document the formal disclosure record for its enterprise software, database, cloud infrastructure, and cloud application business. Current reports cover quarterly operating and financial results, cloud revenue categories, dividends on common stock and mandatory convertible preferred stock, and the company’s NYSE-listed common stock and depositary shares.
Oracle’s SEC record also includes proxy and 8-K disclosures on board composition, executive appointments, compensation arrangements, annual meeting voting matters, material agreements, capital-structure matters, and other material events tied to corporate governance and financial reporting.
Oracle (ORCL) Form 4: Company officer Mark Hura, Pres., Global Field Operations, reported a grant of stock options on 10/23/2025. The award covers 428,465 options with an exercise price of $280.07 per share and an expiration date of 10/23/2035.
Following the grant, 428,465 derivative securities are beneficially owned, held directly. The options vest 25% each year on the anniversary of the grant date.
Oracle (ORCL) reported an insider equity award: Vice Chairman and Director Jeffrey Henley received 32,135 restricted stock units on 10/23/2025, as shown on a Form 4. Each RSU represents the right to receive one share of common stock at settlement.
The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. The filing lists the award as Direct (D) ownership.
Oracle Corp (ORCL) filed a Form 4 for CEO and Director Safra Catz detailing an equity award. On 10/23/2025, Catz was granted 32,135 restricted stock units.
Each RSU represents the right to receive one share of Oracle common stock at settlement. The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. Following the reported transaction, 32,135 derivative securities were beneficially owned, with ownership reported as direct.
Oracle Corp (ORCL) executive Maria Smith, EVP and Chief Accounting Officer, reported an equity award on a Form 4. On 10/23/2025, she was granted 35,706 restricted stock units (RSUs) (Transaction Code: A) at a price of $0.
Each RSU represents the right to receive one share of common stock at settlement. The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. Following the reported transaction, 35,706 derivative securities were beneficially owned directly.
Oracle (ORCL): EVP and Chief Legal Officer reported equity awards. On 10/23/2025, the reporting person acquired 49,988 restricted stock units (RSUs) at a $0 price, which vest in four equal annual installments beginning on the first anniversary of the grant. The filing also records 142.94 dividend equivalents accrued on earned RSUs granted on 11/05/2022, calculated using Oracle’s closing price of $280.07 on 10/23/2025, the dividend payment date.
Following these transactions, direct derivative holdings reported were 159,157.199 after the dividend-equivalent entry and 49,988 for the new RSU grant. Each RSU represents the right to receive one share of common stock at settlement.
Oracle (ORCL) executive Maria Smith, EVP and Chief Accounting Officer, reported sales of 10,000 shares of Oracle common stock. The transactions included 5,000 shares at $280.00 on October 21, 2025 and 5,000 shares at a weighted‑average price of $280.6245 on October 23, 2025.
After these sales, she beneficially owns 47,083 shares directly. The filing notes the second trade was executed in multiple transactions within the stated price range; the weighted average price is reported.
Oracle Corp (ORCL) insider filing: the Chief Executive Officer reported an open-market sale (Transaction Code S) of 40,000 shares on 10/21/2025 at a weighted average price of $276.6377. The filing notes the sale was executed in multiple trades priced between $276.60 and $276.91.
Following this transaction, the reporting person beneficially owned 154,030 shares on a direct basis.
Oracle (ORCL) received a Form 144 notice for a proposed sale of 5,000 shares of common stock. The notice lists an aggregate market value of $1,403,122.87, with sales expected on 10/23/2025 through Fidelity Brokerage Services LLC on the NYSE.
The shares were acquired via restricted stock vesting in four tranches: 1,286 (12/05/2023), 1,620 (08/03/2024), 1,240 (08/04/2024), and 854 (09/15/2024), totaling 5,000. The filing also notes a separate sale by Maria Smith of 5,000 shares on 10/21/2025 for $1,400,000.00.
Oracle (ORCL) received a Form 144 notice for a proposed insider sale of 49,365 shares of common stock. The filing lists an aggregate market value of $13,387,294.35, with an approximate sale date of October 28, 2025.
The shares are indicated for sale on the NYSE through APEX Clearing. The seller’s holdings include awards acquired via RSUs from Oracle on multiple dates, such as 01/07/2013, 05/31/2018, 05/31/2020, 05/31/2021, 05/31/2022, 05/31/2024, and 05/31/2025.
Oracle (ORCL) filed a Form 144 notice for a proposed sale of 40,000 common shares. The filing lists an aggregate market value of $11,065,506.10, with an approximate sale date of 10/21/2025 on the NYSE through Fidelity Brokerage Services LLC.
The shares to be sold were acquired via restricted stock vesting: 37,270 shares on 09/15/2025 and 2,730 shares on 09/19/2025. Shares outstanding are stated as 2,841,714,000. In the past three months, the person for whose account the sale is proposed sold 21,241 shares on 09/12/2025 for gross proceeds of $6,310,864.10.